Skip to main content
. 2012 Jun 18;11:71. doi: 10.1186/1475-2840-11-71

Table 2.

Comparison of laboratory results between the progression group and the non-progression group at first /follow-up visits

Variable
Initial/ follow-up visit 		Progression Group (n = 198) Non-progression Group (n = 168) p value
Fasting glucose (mmol/L)
 6.15 ± 1.81
 5.49 ± 1.25
 <0.001
7.84 ± 1.80
 5.30 ± 1.22
 0.005
OGTT (mmol/L)
 10.09 ± 4.17
 8.65 ± 3.41
 <0.001
9.68 ± 3.79
 8.47 ± 3.38
 0.002
Fasting insulin (mU/L)
 13.50 ± 26.58
 12.57 ± 27.04
 0.010
14.43 ± 19.01
 17.10 ± 60.81
 0.002
Postprandial insulin (mU/L)
 78.31 ± 117.74
 62.43 ± 65.86
 0.388
80.27 ± 71.31
 88.35 ± 107.35
 0.868
Bennett index
 1.79 ± 0.65
 0.41 ± 0.56
 <0.001
 
 0.95 ± 0.84
 0.67 ± 0.95
 <0.001
HbA1c (%)
 6.73 ± 1.40
 6.24 ± 0.98
 0.001
6.79 ± 1.53
 6.07 ± 0.78
 <0.001
hsCRP (mg/L)
 9.28 ± 13.56
 13.34 ± 22.51
 0.600
6.55 ± 12.01
 2.68 ± 4.14
 0.048
BUN (mmol/L)
 5.44 ± 1.59
 5.45 ± 1.50
 0.941
6.06 ± 1.90
 5.70 ± 1.48
 0.623
Creatinine (umol/L)
 84.47 ± 18.34
 89.90 ± 36.51
 0.671
93.11 ± 23.46
 87.28 ± 18.87
 0.585
Urine acid (umol/L)
 339.83 ± 76.41
 339.30 ± 85.77
 0.878
358.38 ± 81.25
 362.80 ± 79.00
 0.966
Urine Ma/Cr
 12.12 ± 49.70
 3.65 ± 18.74
 0.011
16.00 ± 69.94
 2.09 ± 3.14
 0.366
GFR (ml/min)
 80.16 ± 25.46
 76.62 ± 28.98
 0.345
73.52 ± 25.48
 71.55 ± 23.33
 0.049
Serum triglyceride (mmol/L)
 2.13 ± 1.72
 1.86 ± 2.01
 0.072
1.76 ± 1.34
 1.65 ± 1.50
 0.207
Serum cholesterol (mmol/L)
 4.58 ± 1.22
 4.18 ± 1.09
 0.103
2.08 ± 0.76
 2.05 ± 0.78
 0.412
HDL (mmol/L)
 1.05 ± 0.23
 1.05 ± 0.26
 0.706
1.06 ± 0.26
 1.14 ± 0.26
 0.246
LDL (mmol/L)
 2.81 ± 0.96
 2.45 ± 0.84
 0.118
2.08 ± 0.76
 2.05 ± 0.78
 0.412
Lpa (mmol/L)
 0.21 ± 0.21
 0.20 ± 0.18
 0.941
0.21 ± 0.17
 0.30 ± 0.49
 0.317
ApoA (mmol/L)
 1.13 ± 0.22
 1.12 ± 0.20
 0.764
1.11 ± 0.22
 1.12 ± 0.29
 0.738
ApoB (mmol/L)
 0.93 ± 0.28
 0.87 ± 0.26
 0.342
0.80 ± 0.25
 0.77 ± 0.23
 0.225
Ejection Fraction
 62.50 ± 9.06
 64.01 ± 6.86
 0.331
  62.62 ± 8.38 62.62 ± 8.20 0.153